FAP and cancer: A wide range of cancer types has been imaged successfully with FAP-radioligands based on small molecules, particularly in those clinical conditions where imaging with [18F]FDG, the most extensively used PET radiopharmaceutical in oncology, has encountered limitations [4,5,6,7,8].